Welcome to the BOC Translational Hub 

The Translational Hub is an Initiative of the Breast Oncology Program at the Dana-Farber/Brigham Cancer Center established to support the collection, processing, and storage of biospecimens from patients enrolled on clinical studies. Our goal is to facilitate such biospecimen collection to provide investigators with optimal samples to complete the highest quality translational research.
The Translational Hub aims to bring the investigators, clinical and research staff and unify our experience, expertise and efforts for our purpose. The purpose of the Translational Hub aligns with DFCI’s mission to understand, treat, cure and prevent cancer. 

Interviews by Dr. Mittendorf

Dr. Mittendorf discusses key takeaways from the Impassion-131 clinical trial investigating first-line atezolizumab in combination with chemotherapy in metastatic triple-negative breast cancer (TNBC) presented at the 2020 ESMO Virtual Congress.
Tweets by @EMittendorfMD
Enjoy the highlights from the 2019 Susan F. Smith Center Executive Council Beyond Boston Luncheon, which features Dr. Mittendorf discussing the success of the Women's Breast Program. 
Dr. Mittendorf discusses advances in breast cancer immunotherapy

Building on Recent Successes
Dr. Mittendorf Discusses Immunotherapy Efforts in Breast Cancer​
Dr. Mittendorf Discusses Rationale for Updating AJCC Staging System